Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hajduk

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Chemical Biology & Drug Design|July 17, 2007
Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategiesJeffrey R Huth, Chang Park, Andrew M Petros, et al.
Journal of Medicinal Chemistry|December 30, 2020
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug DesignJustin D Dietrich, Kenton L Longenecker, Noel S Wilson, et al.
ACS Chemical Biology|November 25, 2010
Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinasesKenneth M Comess, Chaohong Sun, Cele Abad-Zapatero, et al.
Nature|May 20, 2005
An inhibitor of Bcl-2 family proteins induces regression of solid tumoursTilman Oltersdorf, Steven W Elmore, Alexander R Shoemaker, et al.
Chemical Biology & Drug Design|June 22, 2007
From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzaeClaude G Lerner, Philip J Hajduk, Rolf Wagner, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Chemical Biology & Drug Design|February 24, 2006
Structure-based optimization of MurF inhibitorsGeoffrey F Stamper, Kenton L Longenecker, Elizabeth H Fry, et al.
Chemical Biology & Drug Design|July 17, 2007
Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategiesJeffrey R Huth, Chang Park, Andrew M Petros, et al.
Journal of Medicinal Chemistry|December 30, 2020
Development of Orally Efficacious Allosteric Inhibitors of TNFα via Fragment-Based Drug DesignJustin D Dietrich, Kenton L Longenecker, Noel S Wilson, et al.
ACS Chemical Biology|November 25, 2010
Discovery and characterization of non-ATP site inhibitors of the mitogen activated protein (MAP) kinasesKenneth M Comess, Chaohong Sun, Cele Abad-Zapatero, et al.
Nature|May 20, 2005
An inhibitor of Bcl-2 family proteins induces regression of solid tumoursTilman Oltersdorf, Steven W Elmore, Alexander R Shoemaker, et al.
Chemical Biology & Drug Design|June 22, 2007
From bacterial genomes to novel antibacterial agents: discovery, characterization, and antibacterial activity of compounds that bind to HI0065 (YjeE) from Haemophilus influenzaeClaude G Lerner, Philip J Hajduk, Rolf Wagner, et al.
Pageof 8